MEF2C levels impact our bodies’ ability to mitigate a host of diseases, including not just MCHS, but also Autism, Alzheimer's, Dementia, and Schizophrenia. (You can read more about these connections in the Additional Research page.)

Our scientific research will therefore generate treatment for MCHS specifically, while also expanding our understanding of these critical neurological diseases.